Press Releases

July 25th, 2023

TORONTO, July 25, 2023 – Aleafia Health Inc. (TSX:AH, OTCQB:ALEAF) (“Aleafia” or the “Corporation”) announces today that the Corporation and certain of its Canadian subsidiaries, Emblem Corp., Emblem Cannabis Corporation, Emblem Realty Ltd., Growwise Health Limited, Canabo Medical Corporation, Aleafia Inc., Aleafia Farms Inc., Aleafia Brands Inc., Aleafia Retail Inc., 2672533 Ontario Inc., and 2676063 […]

July 14th, 2023

TORONTO, ONTARIO July 14, 2023 (GLOBE NEWSWIRE) – Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) and Aleafia Health Inc. (TSX: AH and OTCQB: ALEAF) (“Aleafia”) are announcing the mutual termination of the binding letter agreement entered into between the parties on June 6, 2023 (the “Letter Agreement”) in […]

June 14th, 2023

Revenue increased 9% to $11.7 million for the period ended March 31, 2023 (“Q4 FY2023”) versus $10.7 million for the period ended March 31, 2022 Net revenue increased 33% to $9.4 million for Q4 FY2023 versus $7.0 million for the period ended March 31, 2022 Revenue increased 24% to $57.4 million for the 12 months […]

June 7th, 2023

The Combined Company (as defined below) is expected to represent C$138 million in trailing distribution and retail revenue from the Canadian, United States and European cannabis end-markets and combined Gross Profit before fair value adjustments of $39 million.(1)(2)(3)(4) On a combined basis, RWB and Aleafia are expected to service approximately 3,000 retail locations in North […]

June 1st, 2023

TORONTO, June 1, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) announces that the Company has entered into a forbearance agreement with NE SPC II LP (“NE SPC”) extending the forbearance period under its loan agreement with NE SPC until June 5, 2023. The forbearance agreement comes in light […]

May 25th, 2023

TORONTO, May 25, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) announces that the Company has entered into an amendment to the terms of the loan agreement with NE SPC II LP (“NE SPC”) dated as of December 24, 2021 and as previously amended by agreements dated March 28, […]

February 13th, 2023

2nd consecutive quarter of positive Adjusted EBITDA[1] 4% Adjusted EBITDA margin[2] places company in top 3 position for profitability amongst its peers[3] 9% growth in adult use revenue[4] over prior quarter; 5% growth in adult-use revenue[5] year over year 40% increase in medical net revenue[6] with $1.1 million record month revenue in November 2022 1st […]

February 7th, 2023

TORONTO, February 7, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) will now announce on Monday, February 13 prior to market open its fiscal year 2023 third quarter results for the period ending December 31, 2022. The Company will also host its earnings conference call the same day at […]

February 1st, 2023

TORONTO, February 1, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) will announce on February 8 prior to market open its fiscal year 2023 third quarter results for the period ending December 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. […]

January 30th, 2023

TORONTO, January 30, 2023 – Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has signed a new European cannabis distribution partner, representing a one-year, approximately $1 million contract[1], significantly bolstering the Company’s record $1.2 million year-to-date sales in its growing international channel. “This new announcement […]

November 28th, 2022

Successful completion of TSX listing review Expansion of adult-use portfolio into key fifth province 5 provinces now selling Aleafia’s adult-use products TORONTO, November 28, 2022 – Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has completed the TSX delisting review […]

November 9th, 2022

Adjusted EBITDA[1] profitability achieved in Q2 FY2023, ahead of plan 21% increase in total revenue year over year to $14.5 23% increase in branded cannabis net revenue[2] year over year to $9.4 million #3 ranking in total retail sales pull through growth among 20 top Canadian LPs[3] #2 milled and #4 pre-roll market share ranking […]

November 2nd, 2022

TORONTO, November 2, 2022 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on November 9 prior to market open its fiscal year 2023 second quarter results for the period ending September 30, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. […]

November 1st, 2022

16 total new listings added to the Sunday Market portfolio by February 2023 9 new Divvy products in profitable flower, vape, and milled categories Kin Slips portfolio expands to include the California brand’s best-selling CBN product Shut Eye Plus CBD-forward brand Noon & Night extends giftable CBD product lineup Innovative Bogart’s Kitchen portfolio adds to […]

September 29th, 2022

TORONTO, September 29, 2022 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the results of the vote on the election of directors at its annual meeting of shareholders held on September 27, 2022 (the “Meeting”). All six nominees set out in the management information […]